Many people are simply unaware of the existence of the FIT test or underestimate its importance in colorectal cancer ...

Exact’s test could compete with Guardant Health’s Shield blood test, which received approval from the Food and Drug ...

As it works to diversify its methods for catching early cases of colorectal cancer, Exact Sciences has put forward clinical ...

While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, ...

The initial results suggest that Exact’s test could be an alternative to others on the market, but the findings come from a ...

A rival CEO's confrontational social media post underscored the high stakes in the race to develop and deploy cancer ...

Commonly used fecal immunochemical tests vary in their performance, which has implications for the benefits and ...

A new GALAXY study reveals Signatera's cell-free DNA test predicts survival rates and chemotherapy benefits for colorectal ...

A snowman picking his nose made people who typically avoid informataion about colorectal cancer more likely to take a quiz ...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced performance ...

Colon cancer is increasingly affecting the younger population. It's essential to be informed about the risk factors and ...